Answer
Cresemba (isavuconazonium sulfate) powder for concentrate for solution for infusion must be administered intravenously over at least 1 hour after reconstitution and dilution to reduce the risk of infusion-related reactions.
Sources for this answer
- CRESEMBA 200mg Powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.2 Posology and method of administration · Version 22Document updated
Sources checked